Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Systemic lupus erythematosus | R-HSA-977105 | map05322 | cefmetazole | 42008 | drug-path |
Asthma | R-HSA-444620 | map05310 | cefmetazole | 42008 | drug-path |
Allograft rejection | R-HSA-9679028 | map05330 | cefmetazole | 42008 | drug-path |
Type I diabetes mellitus | R-HSA-5683209 | map04940 | cefmetazole | 42008 | drug-path |
Amyotrophic lateral sclerosis (ALS) | Q8NDH6-2 | 0 | cefmetazole | 42008 | drug-path |
MAPK signaling pathway | R-HSA-9652817 | map04010 | cefmetazole | 42008 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | asiaticoside | 11954171 | drug-path |
Chronic myeloid leukemia | R-HSA-9680350 | map05220 | asiaticoside | 11954171 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | asiaticoside | 11954171 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | asiaticoside | 11954171 | drug-path |
Graft-versus-host disease | R-HSA-1643685 | map05332 | oxprenolol | 4631 | drug-path |
Natural killer cell mediated cytotoxicity | R-HSA-5218921 | map04650 | oxprenolol | 4631 | drug-path |
Autoimmune thyroid disease | R-HSA-1643685 | map05320 | oxprenolol | 4631 | drug-path |
Adherens junction | R-HSA-451386 | map04520 | oxprenolol | 4631 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | oxprenolol | 4631 | drug-path |
Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | oxprenolol | 4631 | drug-path |
Allograft rejection | R-HSA-9679028 | map05330 | oxprenolol | 4631 | drug-path |
Type I diabetes mellitus | R-HSA-5683209 | map04940 | oxprenolol | 4631 | drug-path |
Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | oxprenolol | 4631 | drug-path |
Calcium signaling pathway | R-HSA-381753 | map04020 | oxprenolol | 4631 | drug-path |